Orissa HC seeks government response on advanced blood testing technology in Odisha

Cuttack: Orissa high court on Wednesday sought a response from the state govt on a PIL seeking implementation of advanced Individual Donor Nucleic Acid Testing (ID-NAT) in all govt-run and affiliated blood banks across Odisha.

The division bench, led by Chief Justice Harish Tandon and Justice M S Raman heard the petition filed by Dr Amarendra Mohapatra, a 64-year-old retired scientist of Indian Council of Medical Research’s Regional Medical Research Centre, Bhubaneswar.

The petitioner urged the state to procure and install ID-NAT systems through the Odisha State Medical Corporation Ltd, replacing the currently used NAT-PCR technology, which he termed as outdated and less effective in detecting infections like HIV, HBV and HCV.

The PIL contended that ID-NAT provides more accurate and timely detection of blood-borne infections and has been adopted by institutions like AIIMS Delhi, AIIMS Rishikesh, AIIMS Bhubaneswar and ILBS Delhi.

Advocate Satya Sundar Kanungo appeared for the petitioner, while additional govt advocate Debasish Tripathy represented the state. The matter was adjourned to Sept 15.

Advanced Individual Donor-Nucleic Acid Testing (ID-NAT) is a highly sensitive molecular technique that directly detects the viral DNA or RNA of infectious agents like HIV, Hepatitis B (HBV), and Hepatitis C (HCV) in individual blood donor samples. This method significantly reduces the “window period” – the time between exposure to a virus and the development of detectable antibodies or antigens – thereby providing a crucial additional layer of safety to the blood supply by detecting infections earlier than traditional serological (antibody/antigen) tests.

Related Posts

‘Did patients come dancing?’ – Rajasthan minister’s remarks about kidney failure case spark row

On Thursday, Congress workers held protests against the “degrading medical conditions of Rajasthan” and attempted to enter the hospital premises. Rajasthan Health Minister Gajendra Singh Khinvsar’s remarks about women diagnosed…

Price cap on 2 key cancer drugs increased by 50%

NEW DELHI: Amid concerns over shortages of two critical cancer medicines, National Pharmaceutical Pricing Authority has approved a 50% hike in ceiling prices of Carboplatin and Cisplatin injections, citing escalating…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

‘Did patients come dancing?’ – Rajasthan minister’s remarks about kidney failure case spark row

‘Did patients come dancing?’ – Rajasthan minister’s remarks about kidney failure case spark row

Price cap on 2 key cancer drugs increased by 50%

Price cap on 2 key cancer drugs increased by 50%

Hospitals can’t force patients to buy medicines from their pharmacies: Maha FDA

Hospitals can’t force patients to buy medicines from their pharmacies: Maha FDA

IIT Bhubaneswar researchers develop portable device for accurate arsenic detection

IIT Bhubaneswar researchers develop portable device for accurate arsenic detection

Bribe of Rs 3 crore: Delhi Police inspector held, senior public servant under CBI scanner

Bribe of Rs 3 crore: Delhi Police inspector held, senior public servant under CBI scanner

No raids till further orders: Maharashtra tells Bombay HC in Patanjali labelling case

No raids till further orders: Maharashtra tells Bombay HC in Patanjali labelling case